![\"\"](\"\/storage\/app\/media\/pharma\/exportation.jpg\")
<\/p>\n<\/p>\n
The Minister of Health issued Decree no. 5 of 2017 announcing some additional rules for importing drugs, raw materials, vaccines, baby milk and medical supplies from reference and non-reference countries. <\/p>\n
For drugs and its raw materials<\/strong>, importation shall be from counties which apply For vaccines, genetic engineering materials and extracts<\/strong>, the international For baby milk<\/strong>, importation will be from referenced countries applying international The Minister of Health issued Decree no. 5 of 2017 announcing some additional rules for importing drugs, raw materials, vaccines, baby milk and medical supplies from reference and non-reference countries.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"yoast_head":"\n
\ninternational monitoring standards and have efficient supervisory authorities which are
\naccredited by international organization specially the WHO WFO, EMA, and FDA.
\nImportation from non-reference counties can be allowed provided that the
\nmanufacturing companies must be following the Good Manufacturing Practices for
\nPharmaceutical Products (GMP<\/abbr>) approved by international organization such as WHO,
\nWFO, EMA, and FDA, or its products are traded in a reference country. <\/p>\n
\nregistration rules will be followed whether the importation is from a reference or
\nnon-refence country according to the ICH GHIDLINES standard. <\/p>\n
\nstandards, or non-referenced countries in case the imported product is traded in a
\nreference country.<\/p>\n","protected":false},"excerpt":{"rendered":"